Skip to content

Clinical trials

Phase 1/2 Glioblastoma trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glioblastoma Phase: Phase 1/2 Country / region: Italy Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20091
20101
20131
20162
20191
20203
20212
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Terminated3
Active, not recruiting2
Recruiting2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer1
Bristol-Myers Squibb1
Eli Lilly and Company1
European Organisation for Research and Treatment of Cancer - EORTC1
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta1
Genenta Science1
GlaxoSmithKline1
InSightec1
Medical Research Council1
Nerviano Medical Sciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glioblastoma14
Diffuse Intrinsic Pontine Glioma2
Ependymoma2
Glioma2
Gliosarcoma2
Osteosarcoma2
Rhabdomyosarcoma2
Sarcoma2
Brain Neoplasms1
Carcinoma, Hepatocellular1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.